Next 10 |
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613 PR Newswire MONTVALE, N.J. , Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug...
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil PR Newswire Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation MONTVALE, N.J. , ...
2023-08-07 08:47:57 ET The Renaissance IPO ETF ( NYSEARCA: IPO ) has stood out this year, with a dynamic growth trend and return of 42% YTD. This impressive gain stands in contrast to the 17% rise of the benchmark S&P 500 Index during the same time period, demonstratin...
REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of Rahul Singhvi, Sc.D., to its Board of Directors. Dr. Singhvi is a biotechnology indu...
EOM Pharmaceuticals (OTCPK:IMUC) has filed to uplist from the Pink Sheets to the Nasdaq. As part of the application, EOM would trade on the Nasdaq under the ticker "EOM." EOM (formerly ImmunoCellular Therapeutics) has two candidates in the clinical stage, EOM613 and EOM147. The former is in p...
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement Combined company will operate as EOM Pharmaceuticals Holdings, Inc. advancing a pipeline of novel immunomodulatory agents including EOM613 currently in cl...
ImmunoCellular Therapeutics Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market PR Newswire LOS ANGELES , June 28, 2021 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announ...
LOS ANGELES , July 2, 2020 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced that, based on the vote count following the Special Meeting of Stockholders held June 26 , 2020, stockholders voted in favor of the proposal to approve ...
The following slide deck was published by ImmunoCellular Therapeutics, Ltd. in conjunction with this Read more ...
LOS ANGELES , Oct. 16, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced that pursuant to an Order of the Superior Court of California, County of Los Angeles , entered on October 3, 2019 , in the matter of David Wiener , derivatively...
News, Short Squeeze, Breakout and More Instantly...
ImmunoCellular Therapeutics Ltd. Company Name:
IMUC Stock Symbol:
OTCMKTS Market:
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613 PR Newswire MONTVALE, N.J. , Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug...
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil PR Newswire Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation MONTVALE, N.J. , ...
REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of Rahul Singhvi, Sc.D., to its Board of Directors. Dr. Singhvi is a biotechnology indu...